ProCE Banner Activity

FLAIR: Switch to Long-Acting CAB + RPV Following Oral Induction in ART-Naive Patients Noninferior to Continued DTG/ABC/3TC at Week 48

Slideset Download
Conference Coverage
Higher patient-reported satisfaction with monthly injectable dual regimen compared with daily oral tablets.

Released: March 11, 2019

Expiration: March 09, 2020

No longer available for credit.

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

This program is supported by independent educational grants from

Gilead

Gilead Text

Janssen

Merck Human Health HIV

ViiV Healthcare